Odnatron (Ondansetron Hydrochloride)

Ondansetron, the active ingredient in Odnatron, is a 5-HT3 receptor antagonist presented as a strength/form for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients. GNH USA supplies Odnatron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Odnatron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Ondansetron is a selective 5‑HT3 antagonist that works on the vomiting pathway by prevent prevent ... ... .

- Chemotherapy‑induced nausea and vomiting: It ... ... . - Radiation‑induced ... . -    ... . - .... . - .... -  ...